Enzyme, the on-chain asset management protocol, acquires a majority stake in MYSO Finance to expand its customized options business.

MYSO x Across Proposal #2 is live on our Snapshot. ⚡️ This proposal is a follow-up to the previously approved initiative to generate stablecoin revenue by deploying idle ACX treasury tokens into a covered call strategy using MYSO Finance. ⤵️ https://t.co/0ZaxEOmY4n

Our product suite powers every stage of the onchain strategy lifecycle, from design to deployment and execution. Here’s a quick recap 👇 • Enzyme​.Blue The all-around Vault-as-a-Service platform. Launch and manage tokenized funds, onchain financial instruments, liquidity pools and more, all from one platform. • Enzyme.Onyx The wallet-tokenization layer for unrestricted digital asset management. Deploy Enzyme Vaults directly on top of your existing wallet setup without migrating or giving up custody. • Enzyme.Myso The premier protocol for creating, trading, and managing fully customizable on-chain options strategies. Create and manage covered calls, cash-secured puts, and other structured products fully onchain, with institutional-grade design. Enzyme is the Global Infrastructure for Tokenized Finance. Explore the full suite → https://t.co/TDarCFyVEY

After months of dedication, the beta of Myso v3 is finally live! Earlier this year, Enzyme acquired @MysoFinance, a protocol empowering users to create & trade fully customizable on-chain calls. Here's why it matters for on-chain investing. 🧵👇

Congratulations to the @MysoFinance team on the latest release. Delighted to support innovative efforts like yours through Nexo Ventures.